Job titles of the future: Nature’s drug designer

Biotech chemists now merge AI with nature-inspired drug design, a role gaining traction by 2026. This specialization accelerates discovery of sustainable therapeutics, reducing Big Pharma's R&D costs. It signals a shift toward AI-nature hybrid innovation, creating high-value jobs in precision medicine and reshaping the bioeconomy's talent demands in an era of ecological awareness.